Here are four quick facts:
1. Eleven analysts agree with this consensus.
2. The higher estimate for the short term price target is $74 while the lower estimate is $64.
3. The 52-week high of the share price is $63.89 and the 52-week low is $48.73.
4. The company has a market cap of $4.3 billion.
More articles on anesthesia:
Dr. Brooke Vanderby joins Illinois Bone & Joint Institute: 4 quick facts
Somnia Anesthesia names Diana Allen VP of patient revenue — 5 quick facts
U.S. Anesthesia Partners, Medical Anesthesia and Pain Management Consultants merge: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
